Interestingly, CSLME also down regulated NF‐κB in MCF‐7 cells, which happens to be a key player in controlling various aspects of cancer progression such as angiogenesis, metastasis, and therapeutic resistance. The gene discussed is NFKB1; the disease is cancer.